Calcium gluconate supplementation is effective to balance calcium homeostasis in patients with gastrectomy

Osteoporosis International

Volumn 26, Issue 3, 2015, Pages 987-995

  Krause, M ^a,b   Keller, J ^a   Beil, B ^a   van Driel, I ^c   Zustin, J ^a   Barvencik, F ^a   Schinke, T ^a   Amling, M ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b DEPARTMENT OF CARDIOLOGY   (Germany)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Calcium supplementation; Fibroosteoclasia; Gastrectomy; Osteoporosis

Indexed keywords

CALCIUM CARBONATE; GLUCOCORTICOID; GLUCONATE CALCIUM; PROTON PUMP INHIBITOR; VITAMIN D; CALCIUM; CARBAMIC ACID; CARBAMIC ACID DERIVATIVE;

ACHLORHYDRIA; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE BIOPSY; BONE MATRIX; BONE METABOLISM; CALCIUM ABSORPTION; CALCIUM BALANCE; CALCIUM HOMEOSTASIS; CALCIUM METABOLISM; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; GASTRECTOMY; HUMAN; HUMAN TISSUE; MALE; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOID; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SECONDARY HYPERPARATHYROIDISM; VITAMIN D DEFICIENCY; ADVERSE EFFECTS; AGED; ANIMAL; BIOPSY; BONE DENSITY; DISEASE MODEL; DRUG EFFECTS; DRUG SCREENING; HOMEOSTASIS; HYPERPARATHYROIDISM, SECONDARY; ILIAC BONE; KNOCKOUT MOUSE; METABOLISM; MIDDLE AGED; OSTEOPOROSIS; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES;

ACHLORHYDRIA; AGED; ANIMALS; BIOPSY; BONE DENSITY; CALCIUM; CALCIUM GLUCONATE; CARBAMATES; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; FEMALE; GASTRECTOMY; HOMEOSTASIS; HUMANS; HYPERPARATHYROIDISM, SECONDARY; ILIUM; MALE; MICE, KNOCKOUT; MIDDLE AGED; OSTEOBLASTS; OSTEOCLASTS; OSTEOPOROSIS; RETROSPECTIVE STUDIES;

EID: 84925498063     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-014-2965-1     Document Type: Article

References (37)

1. Zaidi M (2007) Skeletal remodeling in health and disease. Nat Med 13(7):791–801. doi:10.1038/nm1593
2. Keller J, Schinke T (2013) The role of the gastrointestinal tract in calcium homeostasis and bone remodeling. Osteop Int J Estab Res COOPERATION Between EUROPEAN FOUNDATION Osteop National Osteop Found USA 24(11):2737–2748. doi:10.1007/s00198-013-2335-4
3. Howgate DJ, Graham SM, Leonidou A, Korres N, Tsiridis E, Tsapakis E (2013) Bone metabolism in anorexia nervosa: molecular pathways and current treatment modalities. Osteop Int J Estab Res COOPERATION Between EUROPEAN FOUNDATION Osteop National Osteop Found USA 24(2):407–421. doi:10.1007/s00198-012-2095-6
4. Ghishan FK, Kiela PR (2011) Advances in the understanding of mineral and bone metabolism in inflammatory bowel diseases. Am J Physiol Gastrointestin Liver Physiol 300(2):G191–G201. doi:10.1152/ajpgi.00496.2010
5. Lim JS, Kim SB, Bang HY, Cheon GJ, Lee JI (2007) High prevalence of osteoporosis in patients with gastric adenocarcinoma following gastrectomy. World J Gastroenterol WJG 13(48):6492–6497
6. Mellstrom D, Johansson C, Johnell O, Lindstedt G, Lundberg PA, Obrant K, Schoon IM, Toss G, Ytterberg BO (1993) Osteoporosis, metabolic aberrations, and increased risk for vertebral fractures after partial gastrectomy. Calcif Tissue Int 53(6):370–377
7. Paakkonen M, Alhava EM, Karjalainen P, Korhonen R, Savolainen K, Syrjanen K (1984) Long-term follow-up after Billroth I and II partial gastrectomy. Gastrointestinal tract function and changes in bone metabolism. Acta Chir Scand 150(6):485–488
8. Straub DA (2007) Calcium supplementation in clinical practice: a review of forms, doses, and indications. Nutri Clin Pract Off Public Am Soc Parent Enteral Nutri 22(3):286–296
9. Schinke T, Schilling AF, Baranowsky A, Seitz S, Marshall RP, Linn T, Blaeker M, Huebner AK, Schulz A, Simon R, Gebauer M, Priemel M, Kornak U, Perkovic S, Barvencik F, Beil FT, Del Fattore A, Frattini A, Streichert T, Pueschel K, Villa A, Debatin KM, Rueger JM, Teti A, Zustin J, Sauter G, Amling M (2009) Impaired gastric acidification negatively affects calcium homeostasis and bone mass. Nat Med 15(6):674–681. doi:10.1038/nm.1963
10. Yang YX, Lewis JD, Epstein S, Metz DC (2006) Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA J Am Med Assoc 296(24):2947–2953. doi:10.1001/jama.296.24.2947
11. Aoki K, Kihaile PE, Wenyuan Z, Xianghang Z, Castro M, Disla M, Nyambo TB, Misumi J (2005) Comparison of prevalence of chronic atrophic gastritis in Japan, China, Tanzania, and the Dominican Republic. Ann Epidemiol 15(8):598–606. doi:10.1016/j.annepidem.2004.11.002
12. Ihamaki T, Sipponen P, Varis K, Kekki M, Siurala M (1991) Characteristics of gastric mucosa which precede occurrence of gastric malignancy: results of long-term follow-up of three family samples. Scandi J Gastroenterol Suppl 186:16–23
13. Breer S, Krause M, Busse B, Hahn M, Ruther W, Morlock MM, Amling M, Zustin J (2012) Analysis of retrieved hip resurfacing arthroplasties reveals the interrelationship between interface hyperosteoidosis and demineralization of viable bone trabeculae. J Orthop Res Off Public Orthop Res Soc 30(7):1155–1161. doi:10.1002/jor.22035
14. Dempster DW, Compston JE, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR, Parfitt AM (2013) Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR histomorphometry nomenclature committee. J Bone Min Res Off J Am Soc Bone Min Res 28(1):2–17. doi:10.1002/jbmr.1805
15. Krause M, Soltau M, Zimmermann EA, Hahn M, Kornet J, Hapfelmeier A, Breer S, Morlock M, Wulff B, Puschel K, Glueer CC, Amling M, Busse B (2014) Effects of long-term alendronate treatment on bone mineralisation, resorption parameters and biomechanics of single human vertebral trabeculae. Euro Cells Mat 28:152–165
16. Roschger P, Paschalis EP, Fratzl P, Klaushofer K (2008) Bone mineralization density distribution in health and disease. Bone 42(3):456–466. doi:10.1016/j.bone.2007.10.021
17. Krause M, Museyko O, Breer S, Wulff B, Duckstein C, Vettorazzi E, Glueer C, Puschel K, Engelke K, Amling M (2014) Accuracy of trabecular structure by HR-pQCT compared to gold standard muCT in the radius and tibia of patients with osteoporosis and long-term bisphosphonate therapy. Osteop Int J Estab Res COOPERATION Between EUROPEAN FOUNDATION Osteop National Osteop Found USA 25(5):1595–1606. doi:10.1007/s00198-014-2650-4
18. Scarff KL, Judd LM, Toh BH, Gleeson PA, Van Driel IR (1999) Gastric H(+), K(+)-adenosine triphosphatase beta subunit is required for normal function, development, and membrane structure of mouse parietal cells. Gastroenterology 117(3):605–618
19. Cunningham J, Locatelli F, Rodriguez M (2011) Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options. Clinic J Am Soc Nephrol CJASN 6(4):913–921. doi:10.2215/CJN.06040710
20. Krause M, Anschutz W, Vettorazzi E, Breer S, Amling M, Barvencik F (2014) Vitamin D deficiency intensifies deterioration of risk factors, such as male sex and absence of vision, leading to increased postural body sway. Gait Post 39(1):166–171. doi:10.1016/j.gaitpost.2013.06.017
21. Recker RR (1985) Calcium absorption and achlorhydria. N Engl J Med 313(2):70–73. doi:10.1056/NEJM198507113130202
22. Heller HJ, Stewart A, Haynes S, Pak CY (1999) Pharmacokinetics of calcium absorption from two commercial calcium supplements. J Clin Pharmacol 39(11):1151–1154
23. Baek KH, Jeon HM, Lee SS, Lim DJ, Oh KW, Lee WY, Rhee EJ, Han JH, Cha BY, Lee KW, Son HY, Kang SK, Kang MI (2008) Short-term changes in bone and mineral metabolism following gastrectomy in gastric cancer patients. Bone 42(1):61–67. doi:10.1016/j.bone.2007.08.027
24. Bisballe S, Eriksen EF, Melsen F, Mosekilde L, Sorensen OH, Hessov I (1991) Osteopenia and osteomalacia after gastrectomy: interrelations between biochemical markers of bone remodelling, vitamin D metabolites, and bone histomorphometry. Gut 32(11):1303–1307
25. Rumenapf G, Schwille PO, Erben RG, Schreiber M, Fries W, Schmiedl A, Hohenberger W (1997) Osteopenia following total gastrectomy in the rat—state of mineral metabolism and bone histomorphometry. Euro Surg Res Europaische Chirurgische Forschung Recherches Chirurgicales Euro 29(3):209–221
26. Adachi Y, Shiota E, Matsumata T, Iso Y, Yoh R, Kitano S (2000) Osteoporosis after gastrectomy: bone mineral density of lumbar spine assessed by dual-energy X-ray absorptiometry. Calcif Tissue Int 66(2):119–122
27. Fleischer J, Stein EM, Bessler M, Della Badia M, Restuccia N, Olivero-Rivera L, McMahon DJ, Silverberg SJ (2008) The decline in hip bone density after gastric bypass surgery is associated with extent of weight loss. J Clin Endocrinol Metab 93(10):3735–3740. doi:10.1210/jc.2008-0481
28. Heiskanen JT, Kroger H, Paakkonen M, Parviainen MT, Lamberg-Allardt C, Alhava E (2001) Bone mineral metabolism after total gastrectomy. Bone 28(1):123–127
29. Schmiedl A, Schwille PO, Stuhler C, Gohl J, Rumenapf G (1999) Low bone mineral density after total gastrectomy in males: a preliminary report emphasizing the possible significance of urinary net acid excretion, serum gastrin and phosphorus. Clin Chem Lab Med CCLM / FESCC 37(7):739–744. doi:10.1515/CCLM.1999.114
30. Thompson GR, Lewis B, Booth CC (1966) Vitamin-D absorption after partial gastrectomy. Lancet 1(7435):457–458
31. Thomson AB, Sauve MD, Kassam N, Kamitakahara H (2010) Safety of the long-term use of proton pump inhibitors. World J Gastroenterol WJG 16(19):2323–2330
32. Corley DA, Kubo A, Zhao W, Quesenberry C (2010) Proton pump inhibitors and histamine-2 receptor antagonists are associated with hip fractures among at-risk patients. Gastroenterology 139(1):93–101. doi:10.1053/j.gastro.2010.03.055
33. Vestergaard P, Rejnmark L, Mosekilde L (2006) Proton pump inhibitors, histamine H2 receptor antagonists, and other antacid medications and the risk of fracture. Calcif Tissue Int 79(2):76–83. doi:10.1007/s00223-006-0021-7
34. Yu EW, Bauer SR, Bain PA, Bauer DC (2011) Proton pump inhibitors and risk of fractures: a meta-analysis of 11 international studies. Am J Med 124(6):519–526. doi:10.1016/j.amjmed.2011.01.007
35. Mattsson JP, Vaananen K, Wallmark B, Lorentzon P (1991) Omeprazole and bafilomycin, two proton pump inhibitors: differentiation of their effects on gastric, kidney and bone H(+)-translocating ATPases. Biochim Biophys Acta 1065(2):261–268
36. Tuukkanen J, Vaananen HK (1986) Omeprazole, a specific inhibitor of H+-K+-ATPase, inhibits bone resorption in vitro. Calcif Tissue Int 38(2):123–125
37. O’Connell MB, Madden DM, Murray AM, Heaney RP, Kerzner LJ (2005) Effects of proton pump inhibitors on calcium carbonate absorption in women: a randomized crossover trial. Am J Med 118(7):778–781. doi:10.1016/j.amjmed.2005.02.007